Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02319369
Brief Title: Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

First Submitted : December 15, 2014
First Submitted that Met QC Criteria : December 17, 2014
First Posted : December 18, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 14, 2021
Last Update Posted : May 18, 2021